Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer

Carcinogenesis

Volumn 26, Issue 8, 2005, Pages 1360-1367

  Thelen, Paul ^a   Scharf, Jens Gerd ^a   Burfeind, Peter ^a   Hemmerlein, Bernhard ^a   Wuttke, Wolfgang ^a   Spengler, Barbara ^b   Christoffel, Volker ^b   Ringert, Rolf Hermann ^a   Seidlová Wuttke, Dana ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Bionorica AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

7 METHYL AROMADENDRIN; ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; APOCYNINE; BELAMCANDA CHINENSIS EXTRACT; CATECHOL DERIVATIVE; FLAVONOID; HISPIDULIN; IRIDIN; IRIGENIN; IRISTECTORIGENIN; ISOFLAVONE DERIVATIVE; MESSENGER RNA; PLANT EXTRACT; PLANT GLYCOSIDE; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN C RECEPTOR; TECTORIGENIN; TECTORUSIDE; TELOMERASE; TETRAHYDROXYMETHOXIISOFLAVONE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR ETS; TRIHYDROXYDIMETHOXYFLAVONE; TRIHYDROXYISOFLAVONE; UNCLASSIFIED DRUG; PRIMER DNA; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BELAMCANDA CHINENSIS; CANCER INHIBITION; CANCER INVASION; CELL IMMORTALIZATION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ISOLATION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL NEOPLASM; GENE ACTIVITY; GENE EXPRESSION REGULATION; HERBAL MEDICINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MEDICINAL PLANT; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUBCUTANEOUS TISSUE TUMOR; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL DIVISION; DRUG EFFECT; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; PHYTOTHERAPY; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BASE SEQUENCE; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; ISOFLAVONES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PHYTOTHERAPY; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 24944445258     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi092     Document Type: Article

References (33)

1. Nelson,P.S. and Montgomery,B. (2003) Unconventional therapy for prostate cancer: Good, bad or questionable? Nat. Rev. Cancer, 3, 845-858.
2. Adlercreutz,H. and Mazur,W. (1997) Phyto-oestrogens and Western diseases. Ann. Med., 29, 95-120.
3. Denis,L., Morton,M.S. and Griffiths,K. (1999) Diet and its preventive role in prostatic disease. Eur. Urol., 35, 377-387.
4. Cos,P., De Bruyne,T., Apers,S., Vanden Berghe,D., Pieters,L. and Vlietinck,A.J. (2003) Phytoestrogens: Recent developments. Planta Med., 69, 589-599.
5. Steiner,M.S. and Raghow,S. (2003) Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk. World J. Urol., 21, 31-36.
6. Chen,C.D., Welsbie,D.S., Tran,C., Baek,S.H., Chen,R., Vessella,R., Rosenfeld,M.G. and Sawyers,C.L. (2004) Molecular determinants of resistance to antiandrogen therapy. Nat. Med., 10, 33-39.
7. Chen,H., Nandi,A.K., Li,X. and Bieberich,C.J. (2002) NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. Cancer Res., 62, 338-340.
8. Abate-Shen,C. (2002) Deregulated homeobox gene expression in cancer: cause or consequence? Nat. Rev. Cancer, 2, 777-785.
9. Ghadersohi,A., Odunsi,K., Lele,S., Collins,Y., Greco,W.R., Winston,J., Liang,P. and Sood,A.K. (2004) Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules. Oncol. Rep., 11, 453-458.
10. Hellawell,G.O., Turner,G.D., Davies,D.R., Poulsom,R., Brewster,S.F. and Macaulay,V.M. (2002) Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res., 62, 2942-2950.
11. Nanni,S., Narducci,M., Della Pietra,L., Moretti,F., Grasselli,A., De Carli,P., Sacchi,A., Pontecorvi,A. and Farsetti,A. (2002) Signaling through estrogen receptors modulates telomerase activity in human prostate cancer. J. Clin. Invest., 110, 219-227.
12. Murphy,G., Knauper,V., Lee,M.H., Amour,A., Worley,J.R., Hutton,M., Atkinson,S., Rapti,M. and Williamson,R. (2003) Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: The specificity is in the detail. Biochem. Soc. Symp., 70, 65-80.
13. Bond,M., Murphy,G., Bennett,M.R., Newby,A.C. and Baker,A.H. (2002) Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. J. Biol. Chem., 277 13787-13795.
14. Span,P.N., Lindberg,R.L., Manders,P., Tjan-Heijnen,V.C., Heuvel,J.J., Beex,L.V. and Sweep,C.G. (2004) Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. J. Pathol., 202, 395-402.
15. PCA3, a highly prostate cancer-specific gene. Urology, 62, 34-43.
16. Igawa,T., Lin,F.F., Lee,M.S., Karan,D., Batra,S.K. and Lin,M.F. (2002) Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. Prostate, 50, 222-235.
17. Thelen,P., Wuttke,W., Jarry,H., Grzmil,M. and Ringert,R.H. (2004) Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells. J. Urol., 171 1934-1938.
18. PCA3, a very sensitive and specific marker to detect prostate tumors. Cancer Res., 62, 2695-2698.
19. Scharf,J.G., Dombrowski,F., Novosyadlyy,R., Eisenbach,C., Demori,I., Kubler,B. and Braulke,T. (2004) Insulin-like growth factor binding protein-1 is highly induced during acute carbon tetrachloride liver injury and potentiates the IGF-I- stimulated activation of rat hepatic stellate cells. Endocrinology, 145, 3463-3472.
20. Ito,H., Onoue,S. and Yoshida,T. (2001) Isoflavonoids from Belamcanda chinensis. Chem. Pharm. Bull. (Tokyo), 49, 1229-1231.
21. Jung,S.H., Lee,Y.S., Lee,S., Lim,S.S., Kim,Y.S., Ohuchi,K. and Shin,K.H. (2003) Anti-angiogenic and anti-tumor activities of isoflavonoids from the rhizomes of Belamcanda chinensis. Planta Med., 69, 617-622.
22. Lee,K.T., Sohn,I.C., Kim,Y.K., Choi,J.H., Choi,J.W., Park,H.J., Itoh,Y. and Miyamoto,K. (2001) Tectorigenin, an isoflavone of Pueraria thunbergiana Benth., induces differentiation and apoptosis in human promyelocytic leukemia HL-60 cells. Biol. Pharm. Bull., 24, 1117-1121.
23. Morito,K., Aomori,T., Hirose,T., Kinjo,J., Hasegawa,J., Ogawa,S., Inoue,S., Muramatsu,M. and Masamune,Y. (2002) Interaction of phytoestrogens with estrogen receptors alpha and beta (II). Biol. Pharm. Bull., 25, 48-52.
24. Seidlova-Wuttke,D., Hesse,O., Jarry,H., Rimoldi,G., Thelen,P., Christoffel,V. and Wuttke,W. (2004) Belamcanda chinensis and the thereof purified tectorigenin have selective estrogen receptor modulator activities. Phytomedicine, 11, 392-403.
25. Griffiths,K. (2000) Estrogens and prostatic disease. International Prostate Health Council Study Group. Prostate, 45, 87-100.
26. Morrissey,C., Bektic,J., Spengler,B., Galvin,D., Christoffel,V., Klocker,H., Fitzpatrick,J.M. and Watson,R.W. (2004) Phytoestrogenes derived from Belamcanda chinensis have an antiproliferative effect on prostate cancer cells in vitro. J. Urol., 172, 2426-2433.
27. Taplin,M.E. and Balk,S.P. (2004) Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence. J. Cell. Biochem., 91, 483-490.
28. Gao,S., Liu,G.Z. and Wang,Z. (2004) Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells. Prostate, 59, 214-215.
29. Pollak,M.N., Schernhammer,E.S. and Hankinson,S.E. (2004) Insulin-like growth factors and neoplasia. Nat. Rev. Cancer, 4, 505-518.
30. Grzmil,M., Hemmerlein,B., Thelen,P., Schweyer,S. and Burfeind,P. (2004) Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression. J. Pathol., 202, 50-59.
31. Yeh,S., Hu,Y.C., Wang,P.H., Xie,C., Xu,Q., Tsai,M.Y., Dong,Z., Wang,R.S., Lee,T.H. and Chang,C. (2003) Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor. J. Exp. Med., 198, 1899-1908.
32. Egeblad,M. and Werb,Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2 161-174.
33. Liu,B., Edgerton,S., Yang,X., Kim,A., Ordonez-Ercan,D., Mason,T., Alvarez,K., McKimmey,C., Liu,N. and Thor,A. (2005) Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res., 65, 879-886.